Inter Parfums
This article was originally published in The Rose Sheet
Executive Summary
Fragrance marketer will offer 4,336,050 shares of its common stock in a public offering, firm says Oct. 10. Selling stockholders are LV Capital USA, Inc. (3,436,050 shares), CEO Jean Madar (450,000 shares) and President Philippe Benacin (450,000 shares), according to Inter Parfums. Madar and Benacin additionally will "grant to the underwriters a 30-day option to purchase up to an additional 650,408 shares of Inter Parfums common stock to cover over-allotments, if any," company notes, adding firm "will not receive any proceeds of the sale of its common stock by the selling stockholders." Offering will be managed by Oppenheimer & Co. and SG Cowen & Co., LLC, with Citigroup Corporate and Investment Banking acting as book runner...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.